B-cell Receptor Pathway Inhibitors Affect CD20 Levels and Impair Antitumor Activity of anti-CD20 Monoclonal Antibodies

Leukemia. 2014 May;28(5):1163-7. doi: 10.1038/leu.2014.12. Epub 2014 Jan 10.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antigens, CD20 / immunology*
  • Humans
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Receptors, Antigen, B-Cell / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD20
  • Receptors, Antigen, B-Cell